Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 5;1(3):ofu107.
doi: 10.1093/ofid/ofu107. eCollection 2014 Dec.

Long-term outcome of pyogenic vertebral osteomyelitis: a cohort study of 260 patients

Arjun Gupta  1 , Todd J Kowalski  2 , Douglas R Osmon  3 , Mark Enzler  3 , James M Steckelberg  3 , Paul M Huddleston  4 , Ahmad Nassr  4 , Jayawant M Mandrekar  5 , Elie F Berbari  3
Affiliations

Long-term outcome of pyogenic vertebral osteomyelitis: a cohort study of 260 patients

Arjun Gupta et al. Open Forum Infect Dis. .

Abstract

Background: The long-term outcome of patients with pyogenic vertebral osteomyelitis (PVO) has not been fully assessed.

Methods: We conducted a retrospective cohort study to describe the long-term outcome of PVO and to assess risk factors for treatment failure in patients evaluated at our institution between 1994 and 2002. Patients were observed until July 1, 2013.

Results: Two hundred sixty patients with PVO were included in this study. Twenty-seven percent (70) of patients developed their infection after an invasive spinal procedure. Staphylococcus aureus accounted for 40% (103) of infections. Forty-nine percent (128) of patients underwent spinal surgery as part of their initial therapy. The median duration of parenteral antimicrobial therapy was 42 days (interquartile range, 38-53). The estimated 2-, 5-, and 10-year cumulative probability of treatment failure-free survival was 72%, 69%, and 69%, respectively. Seventy-five percent of patients who developed treatment failure did so within 4.7 months of diagnosis. Residual neurological defects and persistent back pain were seen in 16% and 32% of patients, respectively. In a multivariate analysis, longer duration of symptoms before diagnosis and having an infection with S. aureus were associated with increased risk of treatment failure.

Conclusions: Increasing duration of symptoms and infection with S. aureus were associated with treatment failure in patients with PVO. Most treatment failures occurred early after initiation of treatment. Pyogenic vertebral osteomyelitis is associated with a high 2-year failure rate. Persistent neurological deficits and back pain are common after therapy.

Keywords: outcome; spondylodiscitis; treatment failure; vertebral osteomyelitis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Kaplan–Meier free of treatment-failure survival curve in patients with pyogenic vertebral osteomyelitis at the Mayo Clinic, Rochester.
Figure 2.
Figure 2.
Kaplan–Meier free of treatment-failure survival curve by primary medical vs surgical therapy in patients with pyogenic vertebral osteomyelitis at the Mayo Clinic, Rochester.
See this image and copyright information in PMC

References

    1. Xarchas KC, Bourandas J. Injuries and diseases of the spine in the ancient times. Spine. 2003;28:1481–4. - PubMed
    1. Eismont FJ, Bohlman HH, Soni PL, et al. Pyogenic and fungal vertebral osteomyelitis with paralysis. J Bone Joint Surg Am. 1983;65:19–29. - PubMed
    1. Carragee EJ. Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am. 1997;79:874–80. - PubMed
    1. Carragee EJ. The clinical use of magnetic resonance imaging in pyogenic vertebral osteomyelitis. Spine. 1997;22:780–5. - PubMed
    1. Chew FS, Kline MJ. Diagnostic yield of CT-guided percutaneous aspiration procedures in suspected spontaneous infectious diskitis. Radiology. 2001;218:211–4. - PubMed